Crestchem Ltd

Crestchem Ltd., a Gujarat-based specialty chemicals manufacturer, reported a stellar performance for the quarter ended March 2026, posting net profit of ₹1.10 crores on revenues of ₹10.23 crores. However, the quarterly strength stands in stark contrast to the company's full-year performance, which saw revenues decline 19.0% year-on-year to ₹25.00 crores in FY25, raising questions about sustainability. The micro-cap stock, currently trading at ₹124.00 with a market capitalisation of ₹36.00 crores, has delivered a disappointing -31.87% return over the past year, significantly underperforming both the broader market and its specialty chemicals peer group.

Crestchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 May 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Crestchem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 15 May 2026. This change is primarily driven by a significant improvement in valuation metrics, despite flat financial performance and underwhelming returns over the past year. The upgrade reflects a nuanced assessment across quality, valuation, financial trends, and technical factors, signalling cautious optimism amid ongoing challenges.

Crestchem Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to a very attractive rating, driven by improved price-to-earnings and price-to-book value metrics. This revaluation comes amid a mixed performance in the specialty chemicals sector and a micro-cap status that continues to offer both opportunities and risks for investors.

Crestchem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 14 May 2026. This shift reflects a combination of flat financial performance, deteriorating returns, and valuation pressures, signalling caution for investors amid challenging market conditions.

Crestchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Crestchem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 Apr 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing challenges in financial performance and valuation metrics. Investors should consider the detailed analysis across quality, valuation, financial trends, and technical indicators before making decisions.

Crestchem Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 13 April 2026. The revision reflects a combination of deteriorating technical indicators, flat financial performance, and disappointing returns relative to benchmarks, signalling heightened caution for investors.

Crestchem Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 April 2026. This change reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite persistent challenges in financial performance and long-term returns, technical indicators have shown signs of mild improvement, prompting a cautious upgrade in the stock’s outlook.

Crestchem Ltd, a specialty chemicals company, has seen its investment rating downgraded from Sell to Strong Sell as of 10 March 2026, reflecting deteriorating technical indicators, flat financial performance, and disappointing returns relative to benchmarks. The downgrade is driven by a combination of factors across quality, valuation, financial trends, and technical analysis, signalling caution for investors amid ongoing challenges.

Crestchem Ltd, a specialty chemicals company, has seen its investment rating upgraded from Strong Sell to Sell as of 5 March 2026, driven primarily by improvements in technical indicators despite ongoing challenges in financial performance and valuation metrics. This nuanced upgrade reflects a cautious optimism amid mixed signals across quality, valuation, financial trends, and technical analysis.

Crestchem Ltd., a micro-cap speciality chemicals manufacturer, reported a net profit of ₹0.72 crores for Q3 FY26 (Oct-Dec'25), marking a 33.33% quarter-on-quarter increase from ₹0.54 crores in Q2 FY26 and a robust 38.46% year-on-year growth from ₹0.52 crores in Q3 FY25. However, the Gujarat-based company's shares have declined sharply, trading at ₹96.50 as of February 13, 2026, down 56.20% over the past year despite the quarterly profit improvement. With a market capitalisation of just ₹29.00 crores, the stock faces severe headwinds from deteriorating operating margins and a bearish technical trend that has persisted since October 2025.

Crestchem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.